CytomX Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update - Form 8-K
MarketScreener,
-Initial data release from Phase 2 study of CX-2029 remains on track for fourth quarter 2021- -Initial data release from Phase…